Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with lung cancer (confirmed by lab or tissue testing) and have received at least one treatment with a type of cancer drug called an immune checkpoint inhibitor
- You have been diagnosed by a doctor with heart inflammation (myocarditis) believed to be caused by immune checkpoint inhibitor treatment
- You are 18 years old or older
- You are willing to take part and have signed a consent form after being fully informed about the study
Who may not be able to join:
- You are currently pregnant or breastfeeding
- You have serious existing heart conditions or have recently had a major heart event, such as a heart attack or severe irregular heartbeat
- You currently have another type of cancer, a disease that weakens your immune system, or a condition where your immune system attacks your own body (such as lupus or rheumatoid arthritis)
- You are unable to attend the required tests and follow-up appointments set out in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The correlation between the dynamic changes in biomarker combinations and disease severity.; Predictive performance of the severity assessment model
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.